[Pseudomonas Aeruginosa Affects the Function of Pulmonary Vascular Endothelial Cells]

Lei Zhang1,2,3, Jun-Yi Wang1,2,3, Xiang He2

  • 1State Key Laboratory of Quality Research in Chinese Medicine,Macau University of Science and Technology,Macao 999078,China.

Insights

Pseudomonas aeruginosa infection disrupts pulmonary vascular endothelial cell function by upregulating PFKFB3 via ATG5, worsening lung inflammation. This study reveals a key mechanism in bacterial exacerbation of lung injury.

Area of Science:

  • Microbiology
  • Cell Biology
  • Immunology

Context:

  • Pseudomonas aeruginosa (PA) infection is a significant cause of hospital-acquired pneumonia and ventilator-associated pneumonia.
  • Pulmonary vascular endothelial cells play a critical role in maintaining lung homeostasis and regulating inflammation.
  • Dysfunction of these cells contributes to the pathogenesis of acute lung injury and inflammation.

Purpose:

  • To investigate the impact of Pseudomonas aeruginosa (PA) infection on human lung microvascular endothelial cell (HULEC-5a) function.
  • To explore the underlying mechanism by which PA exacerbates lung inflammation in a mouse model.
  • To examine the roles of autophagy-related gene 5 (ATG5) and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in PA-induced endothelial cell dysfunction.

Summary:

  • PAO1 infection of HULEC-5a cells upregulated PFKFB3, downregulated CDH5 and VE-cadherin, and increased lactate levels, indicating endothelial dysfunction.
  • Knockdown of PFKFB3 partially restored CDH5 and VE-cadherin levels and reduced lactate. Knockdown of ATG5 exacerbated PFKFB3 upregulation and CDH5/VE-cadherin downregulation.
  • PA-infected mice exhibited lung inflammation, increased PFKFB3, and decreased VE-cadherin in lung endothelial cells.

Impact:

  • PA infection disrupts pulmonary vascular endothelial cell function, potentially through the ATG5-PFKFB3 pathway, contributing to lung inflammation.
  • This study identifies PFKFB3 as a key mediator in PA-induced endothelial cell dysfunction and lung inflammation.
  • Findings provide insights into the molecular mechanisms of bacterial pneumonia and suggest potential therapeutic targets for mitigating lung injury.